THE WOODLANDS, Texas, Sept. 2 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the Thomas Weisel Partners Healthcare Conference at the Four Seasons Hotel in Boston, Massachusetts on Wednesday, September 9, 2009 at 9:45 a.m. Eastern Time. Dr. Sands will provide an overview of Lexicon's clinical and preclinical development programs and corporate objectives.
About Lexicon
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by the company's research team. The company has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.
Lexicon Pharmaceuticals, Inc.
